Suggest a question

Due to the high efficiency of suspended clinical study of the treatment of prostate cancer @ Slo-Tech Jump to content Site Map News O3b got four more satellites :: yesterday vanity fair 1998 at 00:03 China: iPhone is a threat to national security :: July 12, 2014 at 20:22 Binney: NSA keeps 80 percent of calls within USA :: July 12, 2014 at 00:23 kid from Mississippi back positive for HIV :: July 11, 2014 at 22:50 Constitutional Court annulled the mandatory retention of traffic data :: July 11, 2014 at 14:48 Invasion of Indian NIC on the Web sent bogus certificates :: July 11, 2014 at 11:24 Apple won the first chips from TMSC's, becoming less dependent on Samsung :: July 10, 2014 at 23:17 New record speed data transfer for copper :: July 9, 2014 at 22:38 The used phones abound vanity fair 1998 personal vanity fair 1998 data :: July 9, 2014 at 20:54 Android shared data connections to Wi-Fi :: July 9, 2014 at 10:34 Yesterday Semifinals most commentated event on Twitter in history :: July 9, 2014 at 9:42 BlackBerryjev vanity fair 1998 Passport will is square :: July 8, 2014 at 20:49 Foxconn vanity fair 1998 prepared for the introduction of robots :: July 8, 2014 at 19:58 Police dog sniffs out media in the fight against child pornography :: July 8, 2014 at 12:04 am in the United States will not be able to travel with electronics vanity fair 1998 evacuated batteries :: July 7, 2014 at 11:06 am Last articles
Suggest a question
Special outs Author:-all-authors Arto BALAST Blaise Blazz enadvatri fossil gendale globalna80 gzibret imagodei vanity fair 1998 Ingo Invictus Jst Carrots Lion29 LuiIII lukcic Magic1 Manu mikic007 MIPE mtosev PacificBlue PaX_MaN Putra Pyr0Beast Ramon dekers RejZoR Relanium SkipEU sparklyslo sss UIO zee Keyword:
SFGate - As reported by the San Francisco Chronicle, American researchers vanity fair 1998 from the UCSF Helen Diller vanity fair 1998 Family Comprehensive Cancer Center, led by Dr.. Charles Ryan completed by early clinical trial efficacy of hormonal medicines for the treatment of metastatic prostate cancer. A medicine containing the active substance abirateron (sold under the name Zytiga, a drug is developed by a British non-profit organization Cancer Research vanity fair 1998 UK), clinical testing are prematurely because it has been shown that treatment of prostate cancer, a new drug extremely vanity fair 1998 effective. The study included 1,088 men with an enlarged prostate, some of which are treated with the steroid prednisone, some abirateron, some placebo. Prostate cancer is one of the most common cancers in men, 5-year survival rate in Slovenia vanity fair 1998 in the period 2001-2005 was 78%. The results of the EUROCARE-4 study of patients diagnosed in 2000-2002 show that the Slovenian survival of patients with prostate vanity fair 1998 cancer significantly lower than the European average. The problem with this cancer is that initially does not cause a lot of problems (develops slowly and is clinically manifested vanity fair 1998 only after 10 to 14 years), it is generally detected only when metastasizes (mostly bones). Let us mention that, while there are blood tests that measure the level of PSA (prostate-specific antigen), which usually indicates the presence of disease, develop are also similar to urine tests. Essential vanity fair 1998 for the existence of prostate cancer cells is the presence of testosterone in the body, so treatment includes hormone therapy, which helps to block the formation of testosterone in the body of the patient. However, after a certain time this therapy becomes vanity fair 1998 ineffective, because the cancer vanity fair 1998 cells learn how to produce a single hormone testosterone. The disease therefore progresses and ends with death. The new drug is first to block the formation of testosterone in the cancer cells. It was to the average stop further spread of the cancer for 16 months (or for such extended time start of chemotherapy), while patients should also suffered much less pain. Medicine vanity fair 1998 as a side effect causes fatigue and high blood pressure. The manufacturer, however, submits that the treatment with this drug with caution in patients with high blood pressure, low levels of potassium in the blood and fluid retention in the body. Definitive clinical trial results will be known by in 2014 and is currently in the research or the product is effective vanity fair 1998 already at the stage when the cancer has not metastasized. Let us mention that the company Celsion and Philips implement clinical study target delivery of drugs in the treatment of bone metastases in the case of prostate vanity fair 1998 cancer. In this study, researchers have developed a process in which the drug molecules doxorubicin wrapped in a lipid envelope, and then the medicine is injected into the patient to the blood, at the site of the tumor by means of focused ultrasound, the lipid envelopes are dissolved and the drug is released and acts on the